Incremental value of stress echocardiography and computed tomography coronary calcium scoring for the diagnosis of coronary artery disease.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 08 01 2019
accepted: 02 03 2019
pubmed: 16 3 2019
medline: 14 6 2019
entrez: 16 3 2019
Statut: ppublish

Résumé

Computed tomography coronary angiography (CTCA) has a higher negative predictive value (NPV) for coronary artery disease (CAD) than stress echocardiography (SE). CT calcium scoring (CTCS) allows detection and quantification of coronary artery calcification (CAC). The NPV of combined SE and CTCS for CAD is not well defined. Consecutive patients from the executive screening program who underwent exercise SE and concomitant CTCA were retrospectively identified between January 2010 and December 2014. Patients with normal SE and CAC score of zero were determined, and the presence or absence of any CAD (obstructive or non-obstructive plaques) on CTCA was confirmed. The NPV of combined SE and CTCS was then re-tested using a validation cohort of subsequent consecutive patients enrolled between January 2015 and July 2018. The initial cohort consisted of 173 patients (19% age > 65 years, 19% diabetic); 40% had normal CTCA, 48% with non-obstructive CTCA (77 with CAC score > 0), and 12% with obstructive CTCA (all with CAC score > 0). There were 16 (9.2%) patients with inducible ischemia on SE. A normal SE had a 93% NPV to exclude obstructive CAD but only 42% NPV to exclude any CAD. A combined normal SE and CTCS had a 100% NPV for obstructive CAD, and 92% for any CAD. In a validation cohort of 111 patients, a normal SE and CAC score of zero had NPV of 100% for obstructive CAD and 92% for any CAD. The combined cohort consisted of predominately low Framingham risk patients; more than 40% (70/181) had CAC score > 0 and 5/70 had obstructive CAD, with the remaining non-obstructive. A concomitant normal SE and CAC score of zero excluded obstructive CAD (NPV 100%) and any CAD in 92% of the testing and validation cohorts. CTCS seems to add incremental risk stratification, particularly for patients with low Framingham score.

Identifiants

pubmed: 30874979
doi: 10.1007/s10554-019-01577-x
pii: 10.1007/s10554-019-01577-x
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1133-1139

Références

Arch Intern Med. 2004 Aug 9-23;164(15):1610-20
pubmed: 15302630
J Am Coll Cardiol. 2004 Aug 18;44(4):923-30
pubmed: 15312881
J Am Coll Cardiol. 2007 May 8;49(18):1860-70
pubmed: 17481445
J Am Soc Echocardiogr. 2007 Sep;20(9):1021-41
pubmed: 17765820
Arch Intern Med. 2007 Dec 10;167(22):2437-42
pubmed: 18071165
Eur Heart J. 2008 Feb;29(4):531-56
pubmed: 18084017
N Engl J Med. 1991 Sep 19;325(12):849-53
pubmed: 1875969
J Am Coll Cardiol. 2010 Dec 14;56(25):e50-103
pubmed: 21144964
J Am Coll Cardiol. 2012 Dec 18;60(24):e44-e164
pubmed: 23182125
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
pubmed: 2407762
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-2959
pubmed: 24239921
Circ Cardiovasc Imaging. 2015 Mar;8(3):null
pubmed: 25711274
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Lancet. 2015 Jun 13;385(9985):2383-91
pubmed: 25788230
J Cardiovasc Comput Tomogr. 2016 Nov - Dec;10(6):435-449
pubmed: 27780758
J Nucl Cardiol. 2018 Jun;25(3):833-841
pubmed: 27804072
J Cardiovasc Echogr. 2017 Apr-Jun;27(2):45-51
pubmed: 28465992
Circulation. 2017 Nov 21;136(21):1993-2005
pubmed: 28847895
Eur Heart J Qual Care Clin Outcomes. 2016 Apr 1;2(2):72-80
pubmed: 29474622
Eur Heart J Qual Care Clin Outcomes. 2016 Oct 1;2(4):245-260
pubmed: 29474724
J Am Coll Cardiol. 2018 Jul 24;72(4):434-447
pubmed: 30025580
Circulation. 1997 Jul 1;96(1):345-54
pubmed: 9236456
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539

Auteurs

Wael AlJaroudi (W)

Division of Cardiovascular Medicine, Clemenceau Medical Center, PO BOX 11-2555, Beirut, Lebanon.

Mohamad Jihad Mansour (MJ)

Division of Cardiovascular Medicine, Clemenceau Medical Center, PO BOX 11-2555, Beirut, Lebanon.
Division of Cardiology, Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Maroun Chedid (M)

Department of Internal Medicine, Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Omar Hamoui (O)

Division of Cardiovascular Medicine, Clemenceau Medical Center, PO BOX 11-2555, Beirut, Lebanon.

Joseph Asmar (J)

Division of Cardiology, Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Layal Mansour (L)

Department of Internal Medicine, Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Elie Chammas (E)

Division of Cardiovascular Medicine, Clemenceau Medical Center, PO BOX 11-2555, Beirut, Lebanon. elie.chammas@cmc.com.lb.
Division of Cardiology, Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon. elie.chammas@cmc.com.lb.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH